Teladoc Health Offers Free Virtual Care for Hurricane Beryl-Affected Texans
Teladoc Health (NYSE: TDOC), a global leader in comprehensive virtual care, is providing complimentary 24/7 general medical telehealth consultations to Texas residents, first responders, and others directly impacted by Hurricane Beryl. Texas individuals displaced or unable to access traditional medical…
Karthik Rao, M.D., Named Chief Medical Officer of Agilon Health
Agilon Health, Inc. (NYSE: AGL), a leader in empowering physicians to innovate healthcare delivery, announced today the appointment of Dr. Karthik Rao as permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao, who has been serving as agilon’s interim CMO…
Henry Schein Inaugurates New Southwestern Distribution Center with Ribbon Cutting Ceremony
Henry Schein, Inc. (Nasdaq: HSIC), a global leader in providing healthcare solutions to dental and medical offices, celebrated the launch of its new 811,000-square-foot Southwestern Distribution Center located in Fort Worth, Texas. This facility stands as the largest single building…
Baxter Releases Annual Corporate Responsibility Report, Emphasizing Lasting Impact
Baxter International Inc. (NYSE), a global medtech leader, has published its 2023 Corporate Responsibility Report, highlighting its ongoing commitment to impactful global healthcare and transparent reporting on environmental, social, and governance issues crucial to stakeholders. José (Joe) E. Almeida, chair,…
WellCare NC Earns NCQA Health Equity Accreditation Early
WellCare of North Carolina, a Medicaid health plan under Centene Corporation (NYSE: CNC), has earned Health Equity Accreditation from the National Committee for Quality Assurance (NCQA) earlier than the mandated mid-year 2025 deadline. This achievement highlights WellCare’s strong commitment to…
The SBB Research Group Foundation Sponsors DKMS Donor Drive
DKMS and the SBB Research Group Foundation collaborated on a volunteer initiative, part of the Champion A Charity Program, supporting local nonprofits. At Night Shift Brewing near Boston, Massachusetts, a charitable event unfolded as DKMS found a staunch advocate in…
Milliman Reviews EO Care’s Cannabinoid Treatment Cost Estimates
EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, has completed its review of EO Care’s proprietary cost impact model. This model is designed for employers and group…
Zura Bio Initiates Warrant Exchange Offer and Seeks Consent
Zura Bio Limited (NASDAQ: ZURA), a clinical-stage immunology company specializing in novel dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) concerning its outstanding IPO warrants.…
Alzamend Neuro Introduces Reverse Stock Split
Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company specializing in treatments for Alzheimer’s disease (AD), bipolar disorder (BD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD), has announced a one-for-ten reverse stock split of its common stock. The…
Harrow to Participate in 2024 ASRS Annual Meeting
Harrow (Nasdaq: HROW), a prominent North American eyecare pharmaceutical company, has announced that its management team will attend the 2024 American Society of Retina Specialists (ASRS) Annual Meeting in Stockholm, Sweden, scheduled from July 17-20, 2024. This premier event gathers…
Masimo Director Urges Shareholders for Boardroom Cultural Reset
Politan Capital Management, along with its affiliates holding an 8.9% stake in Masimo Corporation (NASDAQ: MASI), has released a statement from Michelle Brennan, an independent director of Masimo: “When I was approached last year about the opportunity to join Masimo’s…
Spotlight Medical Raises €6.2M for AI Cancer Prognosis Tests
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, has secured €6.2 million in seed funding. The investment round was led by Kurma Partners and Heal Capital. “This…